AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Erlotinib Hydrochloride Equivalent To Erlotinib

18 registrations across 1 African market— 18 active

Markets with Erlotinib Hydrochloride Equivalent To Erlotinib

Recent registrations

Brand / ProductMarketHolderStatusExpires
EGROTIB 100🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJun 2028
EGROTIB 150🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJun 2028
EGROTIB 25🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJun 2028
BINIT 100🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
BINIT 150🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
ERLOTINIB ZYDUS 25🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
EXONEO 150 mg🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
TARCEVA 150 mg🇿🇦South AfricaRoche Products (Pty) LtdactiveJan 1900
ERLOTINIB 25 mg ADCO🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
BINIT 25🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
TARCEVA 25 mg🇿🇦South AfricaRoche Products (Pty) LtdactiveJan 1900
TARCEVA 100 mg🇿🇦South AfricaRoche Products (Pty) LtdactiveJan 1900
EXONEO 25 mg🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
EXONEO 100 mg🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
ERLOTINIB 100 mg ADCO🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
ERLOTINIB 150 mg ADCO🇿🇦South AfricaAdcock Ingram LimitedactiveJan 1900
ERLOTINIB ZYDUS 100🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
ERLOTINIB ZYDUS 150🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900

Erlotinib Hydrochloride Equivalent To Erlotinib in Africa — Regulatory Overview

Erlotinib Hydrochloride Equivalent To Erlotinib is registered across 1 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 18 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.